You are here » Home » Companies » Company Overview » Neuland Laboratories Ltd

Neuland Laboratories Ltd.

BSE: 524558 Sector: Health care
NSE: NEULANDLAB ISIN Code: INE794A01010
BSE 00:00 | 08 Apr 330.90 16.45
(5.23%)
OPEN

327.00

HIGH

362.90

LOW

323.05

NSE 00:00 | 08 Apr 329.45 14.65
(4.65%)
OPEN

316.00

HIGH

358.70

LOW

316.00

OPEN 327.00
PREVIOUS CLOSE 314.45
VOLUME 3904
52-Week high 753.60
52-Week low 247.30
P/E 13.28
Mkt Cap.(Rs cr) 425
Buy Price 315.00
Buy Qty 200.00
Sell Price 339.00
Sell Qty 7.00
OPEN 327.00
CLOSE 314.45
VOLUME 3904
52-Week high 753.60
52-Week low 247.30
P/E 13.28
Mkt Cap.(Rs cr) 425
Buy Price 315.00
Buy Qty 200.00
Sell Price 339.00
Sell Qty 7.00

Neuland Laboratories Ltd. (NEULANDLAB) - Chairman Speech

Company chairman speech

Dear friends

The year gone by has been a demanding one as we saw external challengescontinue to impact the industry and we dealt with the issues surrounding our internalcapabilities as well as the external factors. Today I can state with confidence that wehave overcome a lot of the issues which have troubled us in the past and we are in abetter position to deal with the challenges likely to come up in the future.

We have spent time focusing on the manufacturing side of the company inorder to fix the challenges which we felt was holding us back. While we continue to workon that front the top line growth we have seen this year is clearly a reflection ofhaving made significant progress on fixing the capacity constraint issues of the past aswell as a few of the market related issues. We have created Manufacturing and R&Dorganization structures which are more suited to meet the needs of the business currentlyand in to the future. We set forth expectations in line with the fast-evolving industrydynamics for the leadership of the Manufacturing and R&D teams.

This year was affected by the spike in raw material prices andvolatility in supply and it took us substantial time to address the issue from aprofitability perspective.

However we used this opportunity to showcase to our customers ourcommitment to their requirements and customers reciprocated by confirming their preferenceof Neuland as one of their key API partners by expanding their product baskets with us.

Since 2013-14 we have been working on de-risking our business byincreasing revenue from Specialty products and the CMS business. The efforts on this fronthad yielded uneven results with troughs and peaks. This year though the foundation hastruly been set for sustainable long-term growth of both the Specialty segment the resultsfor which we have seen even in FY19 and the CMS business. For the CMS business this isevident through the increase in the number of projects entering the system.

During the last year we recruited key people for the Leadership teamacross functions and spent time on integrating them aligning them with the company'svalues culture and more importantly goals and aspirations. We are setting theorganizational foundations for a company which can grow fast in a sustainable manner.

With a few blocks of the newly acquired facility ready for theproduction of intermediates and the prospect of scaling up APIs from the facility in thecoming year I believe we are in a fundamentally strong place to drive growth in short andmedium terms as we have visibility on business from all segments.

Finally on behalf of the board of Director I would like to thank youfor your continued trust confidence and support.

With Best Regards

Dr. Davuluri Rama Mohan Rao

Chairman & Managing Director